🇺🇸 Anthelios Sx in United States

FDA authorised Anthelios Sx on 21 July 2006

Marketing authorisations

FDA — authorised 21 July 2006

  • Status: approved

FDA — authorised 21 July 2006

  • Application: NDA021502
  • Marketing authorisation holder: LOREAL USA
  • Local brand name: ANTHELIOS SX
  • Indication: CREAM — TOPICAL
  • Status: approved

Read official source →

Anthelios Sx in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Dermatology approved in United States

Frequently asked questions

Is Anthelios Sx approved in United States?

Yes. FDA authorised it on 21 July 2006; FDA authorised it on 21 July 2006.

Who is the marketing authorisation holder for Anthelios Sx in United States?

Marketing authorisation holder not available in our data.